Clinical Trial Update: The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effects of MDMA on prefrontal and amygdala activation in individuals with PTSD was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Yale University | Conditions: Post Traumatic Stress Disorder | Phase 1 | Status: WITHDRAWN